Kestra Medical Technologies, Ltd. (KMTS)
NASDAQ: KMTS · Real-Time Price · USD
21.57
+0.68 (3.26%)
Jul 23, 2026, 4:00 PM EDT - Market closed

KMTS Income Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2021
Period Ending
Apr '26 Apr '25 Apr '24 Apr '23 Apr '21
95.1359.8227.817.63-
Revenue Growth (YoY)
59.03%115.05%264.54%--
Cost of Revenue
46.2635.6127.4518.28-
Gross Profit
48.8624.210.36-10.65-
Selling, General & Admin
164.12114.9469.9454.0113.9
Research & Development
19.4815.6515.4915.7618.81
Total Operating Expenses
183.6130.5985.4369.7732.71
Operating Income
-134.74-106.38-85.06-80.42-32.71
Interest Income
8.353.2---
Interest Expense
-7.55-7.73-6.23-5.63-1.17
Other Non-Operating Income (Expense)
2.62-2.77-2.81.83-0.04
Total Non-Operating Income (Expense)
3.42-7.3-9.03-3.8-1.21
Pretax Income
-131.32-113.68-94.1-84.22-33.91
Provision for Income Taxes
0.290.140.020.020.19
Net Income
-131.61-113.81-94.12-84.24-34.1
Net Income Attributable to Preferred Dividends
-12.326.722.5-
Net Income to Common
-131.61-126.14-100.84-86.74-34.1
Shares Outstanding (Basic)
5425200-
Shares Outstanding (Diluted)
5425200-
Shares Change (YoY)
120.41%23.63%18793753.02%--
EPS (Basic)
-2.43-5.13-5.07-820.00-
EPS (Diluted)
-2.43-5.13-5.07-820.00-
Free Cash Flow
-116.6-100.54-84.46-69.64-30.23
Free Cash Flow Per Share
-2.15-4.09-4.25-658192.00-
Gross Margin
51.37%40.47%1.30%-139.59%-
Operating Margin
-141.65%-177.84%-305.83%-1054.01%-
Profit Margin
-138.36%-190.28%-338.39%-1104.04%-
FCF Margin
-122.57%-168.09%-303.66%-912.74%-
EBITDA
-126.03-98.41-73.5-80.42-32.29
EBITDA Margin
-132.49%-164.52%-264.27%-1054.01%-
EBIT
-134.74-106.38-85.06-80.42-32.71
EBIT Margin
-141.65%-177.84%-305.83%-1054.01%-
Effective Tax Rate
-0.22%-0.12%-0.03%-0.02%-0.55%
SEC Filings: 10-K · 10-Q